What’s New in HCC

 

What’s New in HCC
07:46

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase II Clinical Trial to Study the Use of Cabozantinib in Patients With HCC Post IO Treatment

FEATURING Stephen L. Chan
  • 494 views
  • March 22, 2023
21:26

NYU Langone

Common TKI Toxicity Management in 2L HCC Treatment

FEATURING Jennifer Wu
  • 197 views
  • May 4, 2023
  • 1
12:22

City of Hope

Role of TKIs After 1L IO in Advanced HCC

FEATURING Daneng Li
  • 143 views
  • April 3, 2023
  • 1
09:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From the Pivotal Phase 2b HERIZON-BTC-01 Study - Zanidatamab in Previously-Treated HER2‑Amplified Biliary Tract Cancer"

FEATURING Shubham Pant
  • 78 views
  • June 21, 2023
  • 1
06:59

ASCO GI 2023 Conference Coverage

ASCO GI 2023 CCTG HE.1 - Phase 3 Study: Palliative RT for Symptomatic HCC and Liver Metastases

FEATURING Laura Dawson
  • 74 views
  • February 6, 2023
31:47

UChicago Medicine

Multidisciplinary Approach to Hepatobiliary Malignancies: A Changing Landscape

FEATURING Anjana A. Pillai
  • 870 views
  • October 26, 2022
  • 4
06:04

PrecisCa

What Is the Role for Systemic Chemo vs. IO for the Treatment of Unresectable HCC?

FEATURING Richard S. Finn
  • 135 views
  • December 9, 2022
  • 2
06:50

Daniel Ahn

Mechanism of Action of TKIs in HCC

  • 109 views
  • March 22, 2023
  • 1
46:36

Yale Cancer Center

Hepatocellular Carcinoma - From Screening to Treatment: Current Practice, Pearls, and Puzzles

FEATURING Tamar Taddei
  • 241 views
  • February 14, 2023